dr. hurvitz on importance of biosimilars in her2 breast cancer
Published 5 years ago • 102 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:46
dr. hurvitz on biosimilars in breast cancer
-
1:38
dr. hurvitz on the impact of biosimilars
-
1:19
dr. hurvitz on the potential global impact of biosimilars in breast cancer
-
1:58
dr. hurvitz discusses role of pertuzumab in her2 breast cancer
-
5:09
the use of biosimilars in her2 breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
1:13
dr. hurvitz on using adcs in her2 breast cancer
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
3:45
old vid 1
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:35
dr. hurvitz on therapeutics for her2 metastatic breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
1:00
dr. dang on the significance of the myl-1401o biosimilar in her2-positive metastatic breast cancer
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer